BNT162b2 vaccine effectiveness in preventing SARS-CoV-2 infection and severe disease

The BNT162b2 vaccine’s effectiveness in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Unlocking clotting mechanisms in caterpillar hemolymph for medical use

Blood is a remarkable material: it must remain fluid inside blood vessels, yet clot as quickly as possible outside them, to stop bleeding. The chemical

March 30, 2024

New European research and innovation project launched to study healthy aging

A new European research and innovation project studying healthy ageing launched this month. This collaborative project has been awarded funding from Horizon Europe, the EU’s

January 24, 2024

Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.